BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo Z, Yao X, Li M, Fang, Fei Y, Cheng Z, Xu Y, Zhu B. Modulating tumor physical microenvironment for fueling CAR-T cell therapy. Adv Drug Deliv Rev 2022;185:114301. [PMID: 35439570 DOI: 10.1016/j.addr.2022.114301] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng J, Yin X, Yun W, Meng X, Huang Z. Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance. Cancer Lett 2023;559:216108. [PMID: 36863506 DOI: 10.1016/j.canlet.2023.216108] [Reference Citation Analysis]
2 Wang Y, Li Z, Mo F, Chen-Mayfield TJ, Saini A, LaMere AM, Hu Q. Chemically engineering cells for precision medicine. Chem Soc Rev 2023;52:1068-102. [PMID: 36633324 DOI: 10.1039/d2cs00142j] [Reference Citation Analysis]
3 Chen K, Dai M, Luo Q, Wang Y, Shen W, Liao Y, Zhou Y, Cheng W. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer. Int J Biochem Cell Biol 2023;155:106358. [PMID: 36584909 DOI: 10.1016/j.biocel.2022.106358] [Reference Citation Analysis]
4 Chao Y, Liu Z. Biomaterials tools to modulate the tumour microenvironment in immunotherapy. Nat Rev Bioeng 2023. [DOI: 10.1038/s44222-022-00004-6] [Reference Citation Analysis]
5 Tian Y, Bai F, Zhang D. New target DDR1: A "double-edged sword" in solid tumors. Biochim Biophys Acta Rev Cancer 2023;1878:188829. [PMID: 36356724 DOI: 10.1016/j.bbcan.2022.188829] [Reference Citation Analysis]
6 Xu T, Wang C, Chen X, Bai J, Wang E, Sun M. Coexpression of c-Jun in multiple-chain DAP-CAR-engineered T-cells for solid tumor therapy. Immunotherapy 2022;14:1457-66. [PMID: 36597720 DOI: 10.2217/imt-2022-0171] [Reference Citation Analysis]
7 Wang L, Chen X, Zhang L, Niu B, Li L, Sun Y, Yuan X. CAR cell design strategies in solid tumors. International Immunopharmacology 2022;113:109345. [DOI: 10.1016/j.intimp.2022.109345] [Reference Citation Analysis]
8 Yan H, Zhang Y, Zhang Y, Li Y, Kong X, Liu D, Li J, Xi Y, Ji J, Ye L, Zhai G. A ROS-responsive biomimetic nano-platform for enhanced chemo-photodynamic-immunotherapy efficacy. Biomater Sci 2022;10:6583-600. [PMID: 36227002 DOI: 10.1039/d2bm01291j] [Reference Citation Analysis]
9 Wang H, Jiang D, Liu L, Zhang Y, Qin M, Qu Y, Wang L, Wu S, Zhou H, Xu T, Xu G. Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory. Onco Targets Ther 2022;15:1229-43. [PMID: 36267609 DOI: 10.2147/OTT.S382540] [Reference Citation Analysis]
10 Ang L, Li J, Dong H, Wang C, Huang J, Li M, Zhao M, Su C, Wu Q. Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer. Bioengineering (Basel) 2022;9:342. [PMID: 35892755 DOI: 10.3390/bioengineering9080342] [Reference Citation Analysis]
11 Yan X, Qi Y, Ren L, Ma J, Xu M, Xia T, Liu S. Silver nanoclusters show advantages in macrophage tracing in vivo and modulation of anti-tumor immuno-microenvironment. J Control Release 2022;348:470-82. [PMID: 35691499 DOI: 10.1016/j.jconrel.2022.06.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]